Suppr超能文献

根据欧盟法规(EC) No 1829/2003对转基因玉米NK603 x MON810进行重新授权评估(申请编号EFSA-GMO-RX-007)。

Assessment of genetically modified maize NK603 x MON810 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-007).

作者信息

Naegeli Hanspeter, Birch Andrew Nicholas, Casacuberta Josep, De Schrijver Adinda, Gralak Mikołaj Antoni, Guerche Philippe, Jones Huw, Manachini Barbara, Messéan Antoine, Nielsen Elsa Ebbesen, Nogué Fabien, Robaglia Christophe, Rostoks Nils, Sweet Jeremy, Tebbe Christoph, Visioli Francesco, Wal Jean-Michel, Broll Hermann, Fernandez Dumont Antonio, Olaru Irina

出版信息

EFSA J. 2018 Feb 26;16(2):e05163. doi: 10.2903/j.efsa.2018.5163. eCollection 2018 Feb.

Abstract

Following the submission of application EFSA-GMO-RX-007 under Regulation (EC) No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide-tolerant and insect-resistant genetically modified maize NK603 x MON810. The data received in the context of this renewal application contained post-market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatic analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the events in maize NK603 x MON810 considered for renewal is identical to the sequence of the originally assessed events, the GMO Panel concludes that there is no evidence in the renewal application EFSA-GMO-RX-007 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize NK603 x MON810.

摘要

在孟山都公司根据(欧盟)第1829/2003号法规提交申请EFSA-GMO-RX-007后,欧洲食品安全局转基因生物小组(GMO小组)被要求对耐除草剂和抗虫转基因玉米NK603×MON810授权申请续期时提交的数据进行科学风险评估。在本次续期申请中收到的数据包括上市后环境监测报告、对文献的系统检索和评估、更新的生物信息学分析,以及申请人或代表申请人进行的其他文件或研究。GMO小组评估了这些数据,以确定在授权期内发现的可能的新危害、暴露变化或新的科学不确定性,而这些在原始申请中并未进行评估。假设续期时考虑的玉米NK603×MON810事件的DNA序列与最初评估的事件序列相同,GMO小组得出结论,在续期申请EFSA-GMO-RX-007中,没有证据表明存在新危害、暴露变化或科学不确定性,会改变对玉米NK603×MON810原始风险评估的结论。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验